Pulmonary Vein Antrum Isolation (PVAI) Plus Scar Homogenization and Non-PV Triggers Ensure Long-term Recurrence-free Survival in Non-paroxysmal Atrial Fibrillation
Status unconfirmed · Not applicable
Conditions studied: Persistent Atrial Fibrillation, Long-standing Persistent Atrial Fibrillation
In brief
This study aims to examine the long-term success rate of catheter ablation in non-paroxysmal atrial fibrillation patients using different ablation strategies such as : (i) pulmonary vein antrum isolation (PVAI) + isolation of left atrial posterior wall, (ii) PVAI plus scar homogenization, (iii) PVAI plus isolation of posterior wall plus ablation of non-PV triggers \[ PVAI: Pulmonary Vein Antrum Isolation Non-PV triggers: Triggers arising from sites other than pulmonary veins\]
Key facts
- Study ID
- NCT01672138
- Run by
- Texas Cardiac Arrhythmia Research Foundation
- People needed
- 186
- Starts
- 2013-02-01
- Expected to finish
- 2020-12-01
- Last updated by the study team
- 2018-11-16
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age ≥ 18 years
- Patients undergoing first catheter ablation for drug-refractory Persistent (PerAF) or long-standing persistent AF (LSPAF)
- Ability to understand and provide signed informed consent
You may not qualify if…
- Previous catheter ablation or MAZE procedure in left atrium
- Reversible causes of atrial arrhythmia such as hyperthyroidism, sarcoidosis, pulmonary embolism etc
Where it is running
- St. david's medical Center — Austin, Texas, United States (enrolling)
- Texas Cardiac arrhythmia Institute, St. David's Hospital — Austin, Texas, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.